Status and phase
Conditions
Treatments
About
The purpose of this study is to determine whether Endostar pumping into vein with Thalidomide are more effective in the treatment of Advanced Colorectal Cancer (ACRC).
Full description
Endostar have anti-tumor activity by against vascular endothelial growth factor.
Thalidomide is a therapeutic for insomnia and vomiting. It is also used for tumor treatment as an Anti-angiogenesis drug and immune regulator in recently years.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
148 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
FU DAI, Master; YANGYI BAO, Bachelor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal